Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Chemical Reviews|February 2, 2022
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer ImmunotherapyKyle M Garland, Taylor L Sheehy, John T WilsonJournal of Leukocyte Biology|August 21, 2019
At the bench: Engineering the next generation of cancer vaccinesDaniel Shae, Jessalyn J Baljon, Mohamed Wehbe, et al.Biorxiv : the Preprint Server for Biology|April 8, 2024
STING-Activating Polymer-Drug Conjugates for Cancer ImmunotherapyTaylor L Sheehy, Alexander J Kwiatkowski, Karan Arora, et al.Biorxiv : the Preprint Server for Biology|February 3, 2025
Macromolecular Diamidobenzimidazole Conjugates Activate STINGKaran Arora, Taylor L Sheehy, Jacob A Schulman, et al.ACS Central Science|September 30, 2024
STING-Activating Polymer-Drug Conjugates for Cancer ImmunotherapyTaylor L Sheehy, Alexander J Kwiatkowski, Karan Arora, et al.Biomaterials|May 7, 2026
A molecularly defined polymeric platform for environmentally responsive activation of STING to enhance cancer immunotherapyJacob A Schulman, Karan Arora, Alexander J Kwiatkowski, et al.Journal of the American Chemical Society|September 12, 2025
Macromolecular Diamidobenzimidazole Conjugates Can Activate Stimulator of Interferon GenesKaran Arora, Taylor L Sheehy, Jacob A Schulman, et al.ACS Applied Materials & Interfaces|August 28, 2025
Nanoparticle Delivery of Alu RNA Adjuvants Enhances Vaccine ImmunogenicityAlexander J Kwiatkowski, Jacob A Schulman, Hayden M Pagendarm, et al.Science Immunology|May 5, 2023
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapyLihong Wang-Bishop, Blaise R Kimmel, Verra M Ngwa, et al.Nature Biomedical Engineering|June 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugatesBlaise R Kimmel, Karan Arora, Neil C Chada, et al.Pageof 1